The best way to protect against pertussis is with vaccines, while preventive antibiotics can be used to protect people who have been exposed and are at high risk of developing severe pertussis.
Pertussis vaccines are recommended for infants, children, adolescents and adults. Five doses of DTaP are recommended for children 2 months through 6 years of age. One dose of Tdap is recommended for those 11 years and older, with a preferred administration at 11 or 12 years of age. Tdap is also recommended for pregnant women during each pregnancy, with a preferred administration at 27-36 weeks gestation. Get clinical information on pertussis vaccines.
Postexposure Antimicrobial Prophylaxis (PEP)
CDC supports targeting postexposure antibiotic use to persons at high risk of developing severe pertussis and to persons who will have close contact with those at high risk of developing severe pertussis. Learn more about use of PEP.Top of Page
CME: Coughing up the Facts on Pertussis - Emerging Trends and Vaccine Recommendations
Posted May 2012
CDC Current Issues in Immunization NetConference
FAQ: Why Are Reported Cases of Pertussis Increasing?
Learn about waning immunity and other factors driving the resurgence of pertussis.
Pertussis: Summary of Vaccine Recommendations
Table of DTaP and Tdap vaccine recommendations across the lifespan
Tdap for Pregnant Women
Information about the best way to protect newborns from pertussis, including safety, side effects, and efficacy of receiving Tdap during pregnancy.
VIDEO – Protecting Patients From Deadly Pertussis: Updated Vaccine Guidelines
Posted Mar 2013
CDC Expert Commentary in Partnership with Medscape, 5:59 minutes
- Page last reviewed: July 29, 2014
- Page last updated: October 10, 2014
- Content source: